Malignant peritoneal cytology and increased mortality risk in stage I non-endometrioid endometrial cancer.

ABSTRACT:

Objective

To examine the survival of women with stage I non-endometrioid endometrial cancer with malignant peritoneal cytology.

Methods

A retrospective observational cohort study was conducted to examine the National Cancer Institute's Surveillance, Epidemiology, and End Results Program from 2010 to 2016. Women with stage I serous, clear cell, carcinosarcoma, undifferentiated, and mixed endometrial cancer with known peritoneal cytology results at hysterectomy were examined (N = 4506). Propensity score inverse probability of treatment weighting was used to balance the measured covariates, and survival outcomes were assessed according to peritoneal cytology results.

Results

Malignant peritoneal cytology was reported in 401 (8.9%) women. In multivariable analysis, older

SUBMITTER: Matsuo K 

PROVIDER: S-EPMC7751572 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature